← Browse by Condition

Medical Condition

insomnia

Total Trials

21

Recruiting Now

21

Trial Phases

Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for insomnia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — insomnia Clinical Trials

How many clinical trials are currently recruiting for insomnia?

ClinicalMetric currently tracks 21 actively recruiting clinical trials for insomnia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 21. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for insomnia?

insomnia research spans Phase 2 (2 trials), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a insomnia clinical trial?

Eligibility criteria for insomnia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

2

Phase 4

3

Top Sponsors

Massachusetts General Hospital 2 trials

Centre Hospitalier Emile Roux 1 trial

Jeff Bridge 1 trial

Riphah International University 1 trial

The University of Hong Kong 1 trial

Recruiting Clinical Trials

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

Centre Hospitalier Emile Roux

Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

Effects of Progressive Muscle Relaxation Exercises During Pregnancy.

Riphah International Universit...

Sleep Intervention in Children With ASD

The University of Hong Kong

The PSP Sleep Course: An Online Sleep Intervention for Public Safety Personnel With Self-reported Sleep Difficulties.

University of Regina

Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia

Beijing Tiantan Hospital

NCT07542756 Phase 4

A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia

University of Pennsylvania

Promoting Sleep to Alleviate Pain - Arthroplasty

Uppsala University

Training in Evidence-based Treatments in Psycho-Oncology

Massachusetts General Hospital

Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury

NCT07136415 Phase 4

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Brigham and Women's Hospital

Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy of NiteCAPP Jr

University of South Florida

Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients

Massachusetts General Hospital

Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders

Chronic Insomnia in Non-Cancer Pain Patients

Germans Trias i Pujol Hospital

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Chinese University of Hong Kon...

NCT06823752 Phase 2

A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.

Woolcock Institute of Medical ...

NCT06093126 Phase 4

Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

Nova Scotia Health Authority

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Universidade do Sul de Santa C...

Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk

University of Calgary

NCT05441280 Phase 2

Pimavanserin for Insomnia in Veterans With PTSD

VA Office of Research and Deve...

Related Conditions

pain (2) quality of life (2) anxiety (2) depressive symptoms (2) cancer (1) depression anxiety disorder (1) suicidal ideation (1) suicide attempted (1) lumbopelvic pain (1) autism spectrum disorder asd (1) digestive endoscopy (1) insomnia disorder (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology